|
Market Cap (24-Jun) $27,342,400 (1,032nd) |
Close (30-Jun) $0.008 |
Volume (30-Jun) 285,280 |
Shortsold (12-Dec) 6,497 (0.00%) (681st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.09 |
EX1 released this announcement to the ASX on 28 April 2023, 8:03. The announcement is marked as price sensitive, and is 4 page(s) in length and 502.59kb in size.
You can view all announcements from EX1 and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from EX1 | |
|---|---|
| Initial Director's Interest Notice - MD | 22 June 2023, 11:52 |
| Change of Director's Interest Notice - CB | 22 June 2023, 11:51 |
| Final Director's Interest Notice - JW | 22 June 2023, 11:50 |
| EX1 early stage success with in house Elastin (ELN) program | 28 April 2023, 8:03 |
| Quarterly Activities Report and Appendix 4C | 27 April 2023, 8:11 |
| Results of Non-Renounceable Rights Issue | 26 April 2023, 8:22 |
| Update - Proposed issue of securities - EX1 | 5 April 2023, 8:13 |
You must be logged in to post a reply.
Exopharm 